Lecture 18 Notes: Immunoprecipitation and Endocytosis

Expected Learning Outcomes (ELOs) for Lecture 18

  • Understand how immunoprecipitations work and what this can tell you about protein-protein interactions.
  • Describe the path an ingested molecule takes as it enters the cell via endocytosis.
  • Analyze data that led to the discovery of receptor-mediated endocytosis.

ELO 1: Understanding Immunoprecipitation (IP)

  • Immunoprecipitation (IP): A technique used to purify a specific protein by binding an antibody to it.
    • Steps involved:
    1. Add a suitable antibody specific to the target protein.
    2. Antibody binds to the protein of interest.
    3. Add Protein A or G to form insoluble antibody-protein complexes.
    4. Centrifuge the solution to pellet the antibody-protein complex and remove supernatant for further analysis.
  • Co-Immunoprecipitation (Co-IP):
    • Used to purify a specific protein and detect its binding partners.
    • Controls for Co-IP include:
    1. Check both target proteins are present in the whole cell lysate (WCL).
    2. Ensure the immunoprecipitated complex contains both proteins being studied.
    3. Use an irrelevant antibody as a control to confirm no non-specific binding occurs.
  • Example of Co-IP use: Identifying the GTPase Ran and its binding partner RhoA, predicting that if Ran is immunoprecipitated, its GAP should also co-immunoprecipitate.

ELO 2: Pathway of Molecules Entering the Cell via Endocytosis

  • Endocytosis: Process by which cells take in molecules by engulfing them with the plasma membrane.
    • Main types of endocytosis:
    • Phagocytosis: Cell takes in large solid particles (e.g., cellular eating by immune cells).
      • Involves pseudopodia and formation of large vesicles (phagosomes).
      • Phagosomes fuse with lysosomes for degradation.
    • Pinocytosis: Cellular intake of fluids and small solutes (cellular drinking).
      • Creates smaller vesicles (<150 nm).
    • Receptor-mediated endocytosis (RME):
      • A targeted form of pinocytosis that uses receptor proteins to selectively accumulate molecules (ligands).
      • Often involves clathrin-coated vesicles that help transport substances into the cell.
  • Endosomal Pathway Overview:
    1. External molecules bind to receptors on the cell surface.
    2. The plasma membrane invaginates and forms an endocytic vesicle.
    3. The vesicle matures into early endosome, then late endosome, and eventually fuses with lysosomes for digestion.

ELO 3: Discovery of Receptor-Mediated Endocytosis (RME)

  • RME Discovery: Research by Brown and Goldstein on familial hypercholesterolemia (FH) revealed mechanistic insights into cholesterol uptake.
    • Key Findings:
    • FH patients have high LDL levels due to faulty receptors responsible for LDL uptake, leading to heart disease.
    • LDL regulates cholesterol synthesis in cells, impacting the balance between endogenous and exogenous sources of cholesterol.
    • Research Steps:
    1. Established that normal cells reduce cholesterol biosynthesis in the presence of LDL.
    2. In FH cells, the synthesis of cholesterol remains unregulated, indicating a defect in the receptor pathway for LDL uptake.
    • Hypothesis Testing: Examining the binding of labeled LDL to cells differentiated between normal and FH cells, confirming the deficiency in binding in FH cells.

Questions for Review

Based on ELO 1:

  1. What is immunoprecipitation, and what is its purpose?
  2. What does it mean when two proteins immunoprecipitate together?
  3. What are good controls to use in IP experiments?
  4. Can you deduce conclusions from given IP data?

Based on ELO 2:

  1. Compare phagocytosis, pinocytosis, and receptor-mediated endocytosis.
  2. List the pathway taken by an internalized molecule in an endosome/phagosome.
  3. Differentiate between early and late endosomes.
  4. Describe the structure and function of lysosomes.
  5. How is the low pH of lysosomes maintained?
  6. What is receptor recycling?
  7. How do lysosomal proteins reach lysosomes, and why don’t they degrade there?

Based on ELO 3:

  1. What is the primary symptom of patients with familial hypercholesterolemia (FH)?
  2. Describe cholesterol biosynthesis in normal cells and FH cells in the absence and presence of LDL.
  3. What data did Brown and Goldstein find about cholesterol metabolism in normal vs. FH individuals?